EUVIMEDEUVIMED entdecken
Crossref

3D microengineered vascularized tumor spheroids for drug delivery and efficacy testing

Jungho Ahn, Da-Hyun Kim, Dong-Jun Koo, Jungeun Lim, Tae-Eun Park, Jungseub Lee, Jihoon Ko, Seongchan Kim, Minjae Kim, Kyung-Sun Kang, Dal-Hee Min, Sung-Yon Kim und 2 weitere

Acta Biomaterialia · 2023-07 · 165 · 153-167

DOI: 10.1016/j.actbio.2022.10.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2023-07. Verfasst von Jungho Ahn und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mechanical and Aerospace Engineering, Seoul National University, Seoul 08826, Republic of Korea; George W. Woodruff School of Mechanica…. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Ministry of Science, ICT and Future Planning, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor angiogenesis is regarded as a promising target for limiting cancer progression because tumor-associated vasculature supplies blood and provides a path for metastasis. Thus, in vitro recapitulation of vascularized tumors is critical to understand the pathology of cancer and identify the mechanisms by which tumor cells proliferate, metastasize, and respond to drugs. In this study, we microengineered a vascularized tumor spheroid (VTS) model to reproduce the pathological features of solid tumors. We first generated tumor-EC hybrid spheroids with self-assembled intratumoral vessels, which enhanced the uniformity of the spheroids and peritumoral angiogenic capacity compared to spheroids composed only with cancer cells. Notably, the hybrid spheroids also exhibited expression profiles associated with aggressive behavior. The blood vessels sprouting around the hybrid spheroids on the VTS chip displayed the distinctive characteristics of leaky tumor vessels. With the VTS chip showing a progressive tumor phenotype, we validated the suppressive effects of axitinib on tumor growth and angiogenesis, which depended on exposure dose and time, highlighting the significance of tumor vascularization to predict the efficacy of anticancer drugs. Ultimately, we effectively induced both lymphangiogenesis and angiogenesis around the tumor spheroid by promoting interstitial flow. Thus, our VTS model is a valuable platform with which to investigate the interactions between tumor microenvironments and explore therapeutic strategies in cancer. STATEMENT OF SIGNIFICANCE: We conducted an integrative study within a vascularized tumor spheroid (VTS) model. We first generated tumor-EC hybrid spheroids with self-assembled intratumoral vessels, which enhanced the uniformity of the spheroids and peritumoral angiogenic capacity compared to spheroids composed only with cancer cells. Through RNA sequencing, we elucidated that the tumor-EC hybrid spheroids exhibited expression profiles associated with aggressive behavior such as cancer progression, invasion and metastasis. The blood vessels sprouting around the hybrid spheroids on the VTS chip displayed the distinctive characteristics of leaky tumor vessels. We further validated the suppressive effects of axitinib on tumor growth and angiogenesis, depending on exposure dose and time. Ultimately, we effectively induced both lymphangiogenesis and angiogenesis around the tumor spheroid by promoting interstitial flow.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAntineoplastic AgentsHumansSpheroids, CellularAxitinibNeovascularization, PathologicTumor Microenvironment

Stichwörter der Autor:innen

Drug screeningLeaky tumor vasculatureMicrofluidicsOrgan-on-a-chipTumor angiogenesisTumor microenvironmentVascularized tumor

Substanzen

AxitinibAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Mechanical and Aerospace Engineering, Seoul National University, Seoul 08826, Republic of Korea; George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA.
  • Adult Stem Cell Research Center and Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul 08826, Republic of Korea.
  • Institute of Molecular Biology and Genetics, Seoul National University, Seoul 08826, South Korea; Program in Neuroscience, Seoul National University, Seoul 08826, South Korea.
  • Department of Mechanical and Aerospace Engineering, Seoul National University, Seoul 08826, Republic of Korea.
  • Ulsan National Institute of Science and Technology, Ulsan 44914, Republic of Korea.
  • Department of Chemistry, Seoul National University, Seoul 08826, Republic of Korea.

Förderung

  • Ministry of Science, ICT and Future Planning
  • National Research Foundation of Korea

Zitieren

APA

Ahn, J., Kim, D. H., Koo, D. J., Lim, J., Park, T. E., Lee, J., Ko, J., Kim, S., Kim, M., Kang, K. S., Min, D. H., Kim, S. Y., Kim, Y., & Jeon, N. L. (2023). 3D microengineered vascularized tumor spheroids for drug delivery and efficacy testing. Acta Biomaterialia, 165, 153-167. https://doi.org/10.1016/j.actbio.2022.10.009

Vancouver

Ahn J, Kim DH, Koo DJ, Lim J, Park TE, Lee J, et al. 3D microengineered vascularized tumor spheroids for drug delivery and efficacy testing. Acta Biomaterialia. 2023;165:153-167. doi:10.1016/j.actbio.2022.10.009

BibTeX
@article{Ahn2023,
  author = {Ahn, Jungho and Kim, Da-Hyun and Koo, Dong-Jun and Lim, Jungeun and Park, Tae-Eun and Lee, Jungseub and Ko, Jihoon and Kim, Seongchan and Kim, Minjae and Kang, Kyung-Sun and Min, Dal-Hee and Kim, Sung-Yon and Kim, YongTae and Jeon, Noo Li},
  title = {3D microengineered vascularized tumor spheroids for drug delivery and efficacy testing},
  journal = {Acta Biomaterialia},
  year = {2023},
  volume = {165},
  pages = {153--167},
  doi = {10.1016/j.actbio.2022.10.009}
}
Kostenlos starten →